✓ Last verified: February 12, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

| Review Scores | ⭐ Positive patient testimonials (Google Reviews) |
| Location | Northeast Wichita, KS (also Overland Park location) |
| Address | 6432 E 34th St N, Suite 100, Wichita, KS 67226 |
| Phone | (316) 260-8700 |
| Website | kmhm.org |
| Treatments | IV Ketamine Infusion, Spravato (Intranasal Esketamine), Transcranial Magnetic Stimulation (TMS), Psychiatric Medication Management, Light Therapy, Pharmacogenomic Testing |
| Conditions Treated | Treatment-Resistant Depression, Major Depressive Disorder with Suicidal Ideation, Anxiety Disorders, PTSD, Bipolar Disorder |
| Cost | Contact for pricing. IV ketamine series follows NIMH protocol — six infusions over 2-3 weeks. KMHM positions IV ketamine as their most cost-effective option. |
| Insurance | Self-pay for IV ketamine (off-label, not insurance-reimbursed); Spravato may be covered |
| KAP Available? | No — medication-management-led model |
| Clinical Lead | Multi-disciplinary team — RNs, Advanced Nurse Practitioners, and Medical Doctors specializing in interventional psychiatry |
Market Position: KMHM is a Spravato-certified clinic in the Wichita metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
Industry pricing reference. KMHM has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | ✓ Yes |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
Sources: CDC PLACES 2023 (Sedgwick County, KS, crude prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.
Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.
11.4% of ketamine inquiries cite anxiety as the primary condition — the third-most-common driver of demand after depression and PTSD. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.
This 5-question summary is matched to the protocols and conditions KMHM treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
KMHM offers Spravato and IV ketamine — a 2-protocol practice. Patients can switch between or combine modalities without changing providers. Confirm specific dosing schedules and which protocols are recommended for your condition during your consult.
Yes — KMHM offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
KMHM treats depression via Spravato (FDA-approved for TRD), and IV ketamine (off-label, evidence-based). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Yes — KMHM treats PTSD. Both Spravato and IV ketamine can be used for trauma. Ketamine for trauma differs from depression treatment: dosing is often lower per session, and pairing the protocol with trauma-focused therapy between sessions is common. A reasonable consult question: whether PTSD patients here typically use ketamine alone or alongside an outside therapist.
Yes — KMHM treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.
Forrest Kennett
July 25, 2022 at 4:46 pmPlease put me in touch with someone who can help me. I’m a 49 year old male. I live in Madisonville Kentucky. My anxiety is horrendous. I can barely leave my house. I don’t have much of a relationship with my kids because I can’t take them anywhere.
Helpful Review